CRISPR Therapeutics Non-Current Deferred Liabilities (Quarterly) Insights

CRISPR Therapeutics AG (CRSP)

55.95 +0.65 (+1.18%) USD | NASDAQ | Jan 13, 14:49

View Non-Current Deferred Liabilities (Quarterly) for CRSP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial